Intravenous infusion of insulin was previously used to achieve glycaemic target for patients in the Intensive Care Unit [12] and those with diabetic ketoacidosis due to the rapid action and shorter half-life [13]. This evidence concerns the gene INS and diabetic ketoacidosis.